US Patent Issued to Memorial Sloan-Kettering Cancer Center on March 1 for "2-hydroxyglutarate as a biomarker for chronic hypoxia" (New York, Massachusetts Inventors)

Press/Media

Period2 Mar 2022

Media coverage

1

Media coverage

  • TitleUS Patent Issued to Memorial Sloan-Kettering Cancer Center on March 1 for "2-hydroxyglutarate as a biomarker for chronic hypoxia" (New York, Massachusetts Inventors)
    Media name/outletUS Fed News
    Country/TerritoryUnited States
    Date2/03/22
    PersonsStephen Ward
View all 1
View less